GMED vs SNN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 17, 2026
GMED
SNN
Investment Advisor Scores
SNN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | GMED | SNN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 17.301 | 13.8504 | SNN |
| PEG Ratio | 1.7253 | 1.2262 | SNN |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 27.0% | 7.4% | GMED |
| Earnings Growth | 66.7% | 70.4% | SNN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 60.6/100 | 63.6/100 | SNN |
| Profit Margin | 18.9% | 10.1% | GMED |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | BUY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
GMED
NeutralMixed signals - no dominant trend phase, RSI 55
SNN
NeutralMixed signals - no dominant trend phase, RSI 59
Fundamentals Snapshot
| Metric | GMED | SNN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 15.8 | 14.1 |
| Trailing P/E | 18.4 | 22.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.1% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | 0.2% | 0.1% |
| EPS | 4.28 | 1.43 |
| Dividend Yield | — | 0.02% |